Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Checkpoint Inhibitor Outcomes Across Child-Pugh A, B, and C Hepatocellular Carcinoma: A Real-World Integrated Health-System Cohort.

Cancer treatment and research communications·2026
Same author

Effects of Force Feedback on Trainee Performance: A Pilot Study of the dV5 Surgical Robot.

Journal of surgical education·2026
Same author

Exercise reduces hepatic pre-metastatic niche formation via TREM-1 signaling in kupffer cells.

BMC medicine·2026
Same author

Refining the boundaries of resectability for colorectal cancer liver metastases with extrahepatic disease-surgical lessons from a nationwide analysis.

Hepatobiliary surgery and nutrition·2026
Same author

Contemporary management of unresectable or borderline operable colorectal cancer liver metastases: a review and modern treatment algorithm.

American journal of surgery·2026
Same author

Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based Data.

Endocrine·2026

Related Experiment Video

Updated: May 2, 2026

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

1.0K

Intrahepatic cholangiocarcinoma.

Kimberly M Brown1, Abhishek D Parmar2, David A Geller3

  • 1Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0541, USA.

Surgical Oncology Clinics of North America
|February 25, 2014
PubMed
Summary

Intrahepatic cholangiocarcinoma (ICC) is a rare cancer with poor prognosis. Surgical resection offers the best chance for a cure, though outcomes remain challenging.

Keywords:
Bile duct neoplasmsCholangiocarcinomaIntrahepatic bile duct cancerIntrahepatic cholangiocarcinomaPeripheral cholangiocarcinoma

More Related Videos

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995

Related Experiment Videos

Last Updated: May 2, 2026

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

1.0K
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995

Area of Science:

  • Hepatobiliary cancers
  • Gastroenterology
  • Surgical oncology

Background:

  • Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy with rising global incidence and poor prognosis.
  • Nonspecific symptoms often lead to late diagnosis at advanced stages.
  • The ICC staging system has been updated, incorporating lesion number, vascular invasion, and lymph node status.

Purpose of the Study:

  • To summarize the current understanding and management of intrahepatic cholangiocarcinoma.
  • To highlight the importance of surgical resection and adjuvant therapies.
  • To provide an overview of prognostic factors and survival rates.

Main Methods:

  • Review of current literature and clinical guidelines for ICC.
  • Analysis of updated staging criteria.
  • Summary of treatment outcomes and survival data.

Main Results:

  • Complete surgical resection to negative margins is the only potentially curative treatment for ICC.
  • Gemcitabine-based adjuvant therapy is an option for unresectable ICC based on limited data.
  • Five-year survival rates post-resection range from 17% to 44%, with median survivals of 19–43 months.

Conclusions:

  • Early diagnosis and complete surgical resection are critical for improving ICC outcomes.
  • Adjuvant therapies play a role in managing unresectable disease.
  • Continued research is needed to improve prognosis for intrahepatic cholangiocarcinoma.